IGFBP3 and familial pancreatic carcinoma: In pancreatic adenocarcinomas the Akt pathway is activated by IGF and the ratio of IGF and its inhibitor IGFBP3, another target of EWS/FLI1 [15], may play a role in the development of pancreatic cancer [16].